Clinical Trial Coverage

Clinical trial coverage refers to whether and how a health plan pays for the routine medical costs of a member who is enrolled in a clinical trial — meaning the ordinary care costs (doctor visits, lab work, hospitalizations) incurred as part of trial participation, as opposed to the experimental intervention itself (which is typically funded by the trial sponsor). The ACA requires non-grandfathered group health plans and marketplace plans to cover routine patient costs for members in approved clinical trials for cancer and other life-threatening conditions.

The practical coverage boundary matters: the clinical trial sponsor typically covers the investigational drug or device and trial-specific procedures. The health plan is responsible for the member's routine care costs that they would normally incur regardless of trial participation — their oncologist's office visits, standard lab work, hospitalizations unrelated to a trial-specific adverse event. Plans cannot drop or penalize members for participating in an approved trial, and they cannot require members to use in-network providers if the trial is conducted at an out-of-network facility, as long as the member obtains a referral or other required authorization. The complexity arises when a procedure or service serves dual purposes — both as standard care and as a trial protocol — and the plan tries to disclaim responsibility as "experimental." For complex cancer cases especially, the line between standard care and trial protocol can be blurry, and members should work with their oncologist and a benefits advocate to document what's routine care and what's trial-funded. Clinical trial denials are a category where external review rights are particularly valuable.

The takeaway: if you or a family member is enrolled or considering enrollment in a clinical trial, ask your plan in writing what routine patient costs will be covered, get the answer documented, and confirm whether out-of-network trial sites are covered. Don't let uncertainty about coverage costs deter someone with a life-threatening condition from accessing a clinical trial that might be their best treatment option.